| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |